In addition, we investigated the relationship between NUF2 expression in the dissected lymph nodes of patients with pathologic N0 NSCLC and their prognosis to determine its usefulness as a lymph node micrometastasis marker. The gene discussed is NUF2; the disease is non-small cell lung carcinoma.